ArticleAnnals of the American Thoracic Society2016
Potential for Therapeutic Benefit among Cystic Fibrosis Populations Excluded from Clinical Trials or Labeling of Marketed Therapies.
Donald R VanDevanter et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.